Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corinne Schaer

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Plos One|May 3, 2011
HVEM signalling promotes colitisCorinne Schaer, Stefanie Hiltbrunner, Bettina Ernst, et al.
The Journal of Clinical Investigation|September 7, 2006
TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethalityNadia Corazza, Sabine Jakob, Corinne Schaer, et al.
Cell Host & Microbe|October 16, 2008
Polyclonal and specific antibodies mediate protective immunity against enteric helminth infectionKathy D McCoy, Maaike Stoel, Rebecca Stettler, et al.
The Lancet. Oncology|October 13, 2022
Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trialAlexandros Papachristofilou, Jens Bedke, Stefanie Hayoz, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Plos One|May 3, 2011
HVEM signalling promotes colitisCorinne Schaer, Stefanie Hiltbrunner, Bettina Ernst, et al.
The Journal of Clinical Investigation|September 7, 2006
TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethalityNadia Corazza, Sabine Jakob, Corinne Schaer, et al.
Cell Host & Microbe|October 16, 2008
Polyclonal and specific antibodies mediate protective immunity against enteric helminth infectionKathy D McCoy, Maaike Stoel, Rebecca Stettler, et al.
The Lancet. Oncology|October 13, 2022
Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trialAlexandros Papachristofilou, Jens Bedke, Stefanie Hayoz, et al.
Pageof 1